[go: up one dir, main page]

Knulst et al., 1994 - Google Patents

Cytokine detection and modulation in acute graft vs. host disease in mice

Knulst et al., 1994

View PDF
Document ID
4854384563308758489
Author
Knulst A
Tibbe G
Bril-Bazuin C
Breedland E
Van Oudenaren A
Benner R
Savelkoul H
Publication year
Publication venue
Mediators of Inflammation

External Links

Snippet

A murine model for acute lethal graft vs. host disease (GVHD) was used to study the role that a number of cytokines play in the development of lethal GVHD. In this study we focused on the role of IL‐1, IL‐2, IL‐4, IL‐6, IFN‐γ and TNF‐α. Lethally irradiated (C57BL× CBA) F1 …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Similar Documents

Publication Publication Date Title
US10934364B2 (en) Method for in vivo expansion of T regulatory cells
Poutsiaka et al. Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated
Shalaby et al. The involvement of human tumor necrosis factors-alpha and-beta in the mixed lymphocyte reaction.
Keates et al. Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice
Piccotti et al. Alloantigen-reactive Th1 development in IL-12-deficient mice
Shlomchik Graft-versus-host disease
Feldmann et al. Role of cytokines in rheumatoid arthritis
Bass et al. Evidence for mouse Th1-and Th2-like helper T cells in vivo. Selective reduction of Th1-like cells after total lymphoid irradiation.
Drobyski et al. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease
Li et al. Il-12 antagonism enhances apoptotic death of T cells within hepatic allografts from Flt3 ligand-treated donors and promotes graft acceptance
Dey et al. Interleukin-12 inhibits graft-versus-host disease through an Fas-mediated mechanism associated with alterations in donor T-cell activation and expansion
DE69622259T2 (en) CD40 BINDING PROTEIN FOR STIMULATING THE IMMUNE RESPONSE
Davidson et al. IL-13 prolongs allograft survival: association with inhibition of macrophage cytokine activation
JP2003502387A (en) Self-adoptive immunotherapy using primed antigen-specific T cells or B cells
ASEA Signalling through NK1. 1 triggers NK cells to die but induces NK T cells to produce interleukin‐4
Aharoni et al. Studies on the mechanism and specificity of the effect of the synthetic random copolymer GLAT on graft-versus-host disease
Kasama et al. Biphasic regulation of the development of murine type II collagen–induced arthritis by interleukin‐12: possible involvement of endogenous interleukin‐10 and tumor necrosis factor α
Ruth et al. Interleukin-18 as an in vivo mediator of monocyte recruitment in rodent models of rheumatoid arthritis
JP2008518882A (en) Anti-4-1BB antibody-containing drug composition for treating or preventing rheumatoid arthritis
Marillier et al. IL‐27p28 is essential for parent‐to‐F1 acute graft‐versus‐host disease
Knulst et al. Cytokine detection and modulation in acute graft vs. host disease in mice
Hecht et al. In vitro and in vivo effects of pentoxifylline on macrophages and lymphocytes derived from autoimmune MRL‐lpr/lpr mice
Benner et al. Cytokine detection and modulation in acute graft vs.
Sakurai et al. Effect of macrophage colony-stimulating factor on mouse NK 1.1+ cell activity in vivo
US20010022976A1 (en) Immunosuppressive and tumour-suppressive bone marrow factor